Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Esophageal infarction.

Rami Hawari1, Pankaj J Pasricha

  • 1Pankaj J. Pasricha, MD University of Texas Medical Branch, Division of Gastroenterology, Internal Medicine Department, 301 University Boulevard, Galveston, TX 77555, USA. jpasrich@utmb.edu.

Current Treatment Options in Gastroenterology
|February 15, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Expert recommendations for the management of refractory gastroesophageal reflux disease in systemic sclerosis: A report from the World Scleroderma Foundation (WSF) Gastrointestinal "Ad hoc committee".

Journal of scleroderma and related disorders·2026
Same author

How microrobots should be translated: A clinical and value-centered readiness framework.

Bioengineering & translational medicine·2026
Same author

Functional Dyspepsia. Reply.

The New England journal of medicine·2026
Same author

Predominant Symptom in Gastroparesis: Relationships to Quality of Life, Treatments, and Outcome.

Neurogastroenterology and motility·2026
Same author

Inflammation rewires the enteric nervous system through neurogenic monocyte recruitment.

The Journal of experimental medicine·2026
Same author

Functional Dyspepsia.

The New England journal of medicine·2026
Same journal

Esophageal Disorders in the Older Adult.

Current treatment options in gastroenterology·2025
Same journal

Endobariatrics: a Still Underutilized Weight Loss Tool.

Current treatment options in gastroenterology·2023
Same journal

Management of Post Ablative Barrett's Esophagus: a Review of Current Practices and Look at Emerging Technologies.

Current treatment options in gastroenterology·2023
Same journal

Inflammatory Bowel Disease Therapy and Venous Thromboembolism.

Current treatment options in gastroenterology·2023
Same journal

Ileal Pouch-Anal Anastomosis in the Older Adult: a Review of Postoperative Outcomes and Pouchitis Treatment.

Current treatment options in gastroenterology·2023
Same journal

Celiac Disease in the Elderly.

Current treatment options in gastroenterology·2023
See all related articles

Acute necrotizing esophagitis, or black esophagus, is a rare condition with unknown causes, likely involving ischemia. Treatment is supportive, but mortality remains high due to underlying health issues.

Area of Science:

  • Gastroenterology
  • Pathology

Background:

  • Esophageal infarction, also known as acute necrotizing esophagitis, presents as a rare condition with a distinct "black esophagus" endoscopic finding.
  • This condition can affect varying lengths of the esophagus, from the distal third to the entire organ.

Purpose of the Study:

  • To describe the characteristics, potential etiology, and management of acute necrotizing esophagitis.
  • To highlight the diagnostic challenges and clinical outcomes associated with this rare esophageal condition.

Main Methods:

  • Review of endoscopic findings characteristic of "black esophagus."
  • Discussion of potential etiological factors, focusing on ischemia and hypoperfusion states.
  • Analysis of current treatment strategies, including supportive care, acid suppression, and gastrointestinal rest.

Related Experiment Videos

Main Results:

  • Esophageal infarction has a dramatic endoscopic appearance but an often-unknown etiology, excluding corrosive injury.
  • Ischemia resulting from hypoperfusion is hypothesized as a key factor in its pathogenesis.
  • Despite supportive treatment, mortality rates are significant, primarily due to comorbid conditions.

Conclusions:

  • Acute necrotizing esophagitis is a severe esophageal condition requiring supportive management.
  • Further research into the etiology of ischemia-related esophageal infarction is warranted.
  • High mortality underscores the importance of managing comorbid conditions in affected patients.